Why Traders Are Watching Tesla, SolarCity, Allergan & Other Stocks Today

Page 2 of 2

Danaher Reports

Danaher Corporation (NYSE:DHR) share are 0.2% in the green after the company reported EPS of $1.25 on revenue of $5.79 billion for its second quarter, beating the consensus estimates by $0.03 per share and $30 million, respectively. Revenue went up by 16.5% year-over-year and operating cash flow from continuing operations jumped by 26% year-over-year to $2.1 billion. Management expects full-year 2016 EPS to come in at $3.53-$3.60 and GAAP EPS to be in the range of $2.79 to $2.86. A total of 46 investors tracked by Insider Monkey had a bullish position in Danaher Corporation (NYSE:DHR) at the end of March, up by six funds from the previous quarter.

Follow Danaher Corp (NYSE:DHR)

Analyst Likes Allergan 

Traders are watching Allergan plc Ordinary Shares (NYSE:AGN) today after analysts at Credit Suisse initiated coverage on the stock with an ‘Outperform’ rating, mainly due to Allergan’s strong pipeline of drugs. The analysts have a 12-month price target of $327, giving shares a 30% upside from current prices. Many analysts like Allergan’s executive team and the company’s shareholder-friendly up-to-$10 billion buyback authorization. At the end of the first quarter, 170 funds owned shares of Allergan plc Ordinary Shares (NYSE:AGN), which makes Allergan the most popular stock among investors in our database.

Follow Allergan Inc (NYSE:AGN)

Disclosure: None


Page 2 of 2